tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Solvonis Therapeutics Maps Out Catalyst-Rich 2026 as CNS Pipeline Gains Momentum
Company AnnouncementsSolvonis Therapeutics Maps Out Catalyst-Rich 2026 as CNS Pipeline Gains Momentum
2d ago
Solvonis’ SVN-015 Accepted into NIDA Program for Addiction Treatment
PremiumCompany Announcements
Solvonis’ SVN-015 Accepted into NIDA Program for Addiction Treatment
21d ago
Solvonis Therapeutics Updates Share Capital Details
PremiumCompany Announcements
Solvonis Therapeutics Updates Share Capital Details
2M ago
Solvonis Therapeutics Streamlines Operations and Enhances R&D Focus
PremiumCompany Announcements
Solvonis Therapeutics Streamlines Operations and Enhances R&D Focus
2M ago
Solvonis Therapeutics Appoints Paul Carter as Non-Executive Director
PremiumCompany Announcements
Solvonis Therapeutics Appoints Paul Carter as Non-Executive Director
2M ago
Solvonis Therapeutics Raises £1.25 Million to Boost CNS Disorder Programs
PremiumCompany AnnouncementsSolvonis Therapeutics Raises £1.25 Million to Boost CNS Disorder Programs
2M ago
Solvonis Therapeutics Expands Pipeline with Awakn Acquisition
Premium
Company Announcements
Solvonis Therapeutics Expands Pipeline with Awakn Acquisition
3M ago
Solvonis Therapeutics Enhances CNS Focus with Exclusive Collaboration and New Equity Issue
Premium
Company Announcements
Solvonis Therapeutics Enhances CNS Focus with Exclusive Collaboration and New Equity Issue
4M ago
Solvonis Therapeutics: Advancing Novel Treatments for Addiction
PremiumCompany Announcements
Solvonis Therapeutics: Advancing Novel Treatments for Addiction
4M ago
Solvonis Advances Three Candidates in PTSD Programme
PremiumCompany Announcements
Solvonis Advances Three Candidates in PTSD Programme
4M ago
Solvonis Therapeutics Advances PTSD Programme with Promising Preclinical Results
PremiumCompany Announcements
Solvonis Therapeutics Advances PTSD Programme with Promising Preclinical Results
4M ago
Solvonis Therapeutics Advances SVN-002 Towards Phase 2b Trial for AUD
PremiumCompany Announcements
Solvonis Therapeutics Advances SVN-002 Towards Phase 2b Trial for AUD
5M ago
Solvonis Therapeutics Raises Funds Through Warrant Exercise
PremiumCompany AnnouncementsSolvonis Therapeutics Raises Funds Through Warrant Exercise
5M ago
Solvonis Chair to Highlight Strategic Leadership at Biotech Event
Premium
Company Announcements
Solvonis Chair to Highlight Strategic Leadership at Biotech Event
5M ago
Solvonis Secures £1 Million to Boost AI Drug Discovery
Premium
Company Announcements
Solvonis Secures £1 Million to Boost AI Drug Discovery
6M ago
Solvonis Therapeutics PLC Announces Change in Major Holdings
PremiumCompany Announcements
Solvonis Therapeutics PLC Announces Change in Major Holdings
6M ago
Solvonis Therapeutics Marks Milestone with AGM Success and Strategic Acquisition
PremiumCompany Announcements
Solvonis Therapeutics Marks Milestone with AGM Success and Strategic Acquisition
6M ago
Solvonis Therapeutics PLC Announces Change in Voting Rights Structure
PremiumCompany Announcements
Solvonis Therapeutics PLC Announces Change in Voting Rights Structure
6M ago
Solvonis Therapeutics Gains Research Coverage from Singer Capital Markets
PremiumCompany Announcements
Solvonis Therapeutics Gains Research Coverage from Singer Capital Markets
6M ago
Solvonis Therapeutics Secures Key U.S. Patent for AI-Driven CNS Compounds
PremiumCompany AnnouncementsSolvonis Therapeutics Secures Key U.S. Patent for AI-Driven CNS Compounds
6M ago
Solvonis Launches AI-Driven CNS Drug Discovery Initiative
Premium
Company Announcements
Solvonis Launches AI-Driven CNS Drug Discovery Initiative
7M ago
Solvonis Advances PTSD Treatment Program with New Candidate Synthesis
Premium
Company Announcements
Solvonis Advances PTSD Treatment Program with New Candidate Synthesis
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >